Johns Hopkins University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).

1,448 total trials 250 currently recruiting 943 completed early-phase tilt top decile by trial count

Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.

Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.

Top-decile sponsor footprint

Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,448 total, page 13 of 29

TERMINATED Phase 4

Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation

NCT03247413

COMPLETED Phase 1

Effects of Psilocybin in Anorexia Nervosa

NCT04052568

COMPLETED Early Phase 1

Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)

NCT03727776

COMPLETED NA

Post-Endoscopic Infection Rate Notifications to Improve the Delivery of Care

NCT03922971

TERMINATED NA

Role of Pre-operative Counseling in the Surgical Patient

NCT03925961

COMPLETED NA

e-CHEC-uP: Scaling up an Efficacious Cancer Screening Intervention for Women With Limited English

NCT03726619

COMPLETED Phase 1

A Personalized Behavioral Intervention to Improve Physical Activity, Sleep and Cognition in Sedentary Older Adults

NCT03959202

TERMINATED NA

Virtual Reality During Procedures in Pediatric Patients

NCT03686176

COMPLETED NA

A Personalized Behavioral Intervention for Older Adults With Musculoskeletal Pain and Sleep Complaints

NCT03921840

COMPLETED Phase 2

Medical Management of Sleep Disturbance During Opioid Tapering

NCT03789214

COMPLETED NA

Antiretroviral Therapy Selection: Comparing HIV Clinical Guidelines With HIV-ASSIST, an Online Decision-support Tool

NCT04080765

COMPLETED NA

Adapted ACHIEVE Curriculum for Community Mental Health Settings

NCT03999892

COMPLETED

Hemostatic Agent Use and Intraoperative Blood Loss in Lumbar Spine Surgery

NCT04058665

COMPLETED NA

Healthy Foods and Education to Treat Diabetes

NCT03991026

COMPLETED

Ocrelizumab Effects on the Metabolome in MS

NCT03873389

COMPLETED NA

Safely Disposing of Surplus Prescription Opioids

NCT03855241

COMPLETED NA

Motivational Interviewing and Air Cleaners for Smokers With COPD (MOVE COPD)

NCT03658538

TERMINATED

Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration

NCT03699618

COMPLETED NA

Promoting Maternal Mental Health and Wellbeing in Neonatal Intensive Care

NCT03942627

TERMINATED NA

Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases

NCT03937856

COMPLETED NA

Buprenorphine Treatment Engagement and Overdose Prevention

NCT03677986

COMPLETED Phase 4

Analysis of Crushed and Whole Tablet Genvoya

NCT03717129

COMPLETED

Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH

NCT04610788

COMPLETED

Be-HealthY: Behavioral Risk Factors for Poor Vascular Health in Youth

NCT03934398

COMPLETED Phase 4

Short-term B-cell Depletion in Relapsing Multiple Sclerosis

NCT03853746

COMPLETED NA

Electronic Communication Augmented Mental Health Care

NCT03925038

COMPLETED Phase 1

Behavioral Pharmacology of THC and D-limonene

NCT03609853

COMPLETED NA

Biologic Mechanisms of Early Exercise After Intracerebral Hemorrhage

NCT04027049

COMPLETED NA

Extinction Learning in Youth With Tourette Syndrome

NCT03765463

COMPLETED Phase 2

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer

NCT04129216

COMPLETED

Post-extubation Assessment of Laryngeal Symptoms and Severity

NCT03726086

COMPLETED NA

Design and Clinical Evaluation of a Smartphone-based Low Vision Enhancement System

NCT03728660

COMPLETED NA

Dietary Intervention Increasing Omega-3 Intake

NCT03806868

COMPLETED

Observational Study of Expected ARF Recovery

NCT03797313

COMPLETED NA

Group Drum-Based Music Therapy Intervention for Parkinson's Disease/Huntington's Disease

NCT05157074

COMPLETED NA

Improving Wisely - Polypharmacy

NCT03857100

COMPLETED NA

A Therapeutic Workplace to Address Poverty and Substance Use

NCT03519009

COMPLETED

Treatment Goals in Psoriatic Arthritis

NCT03620188

COMPLETED

A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women

NCT03774641

COMPLETED NA

mHealth Physical Activity Trial for Older HIV-infected Adults (mFIT)

NCT03708640

COMPLETED

Dual Sensory Impairment Low Vision Rehabilitation (LVR) Initiative

NCT03664349

COMPLETED NA

Auricular Point Acupressure to Self-Manage Chronic Pain or Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors: Effectiveness and Scientific Underpinnings

NCT03697200

COMPLETED

Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC)

NCT03669822

COMPLETED NA

Meal-Based Exposure and Response Prevention in Anorexia Nervosa

NCT03747835

TERMINATED Phase 1

Trial of OnabotulinumtoxinA for Depression in Parkinson Disease

NCT03069911

COMPLETED Phase 1

Single Dose Truvada Study

NCT03719053

COMPLETED NA

Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy

NCT03728582

COMPLETED NA

The BSHAPE Intervention Program for Safety and Health of Survivors of Cumulative Trauma

NCT03664362

COMPLETED Early Phase 1

Cognitive Effects of Nimodipine in Patients With Schizophrenia

NCT03671525

COMPLETED Phase 1

Effects of Commonly Used Medications on Mood and Choice

NCT03652740

← Previous Page 13 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 201
Phase 2 198
Phase 3 44
Phase 4 81

What is open in the Johns Hopkins University pipeline

250 recruiting of 1,448 indexed (17% open); 943 completed (65%).

Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).

Top condition: Hypertension (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.